Atezolizumab/nivolumabType 1 diabetes mellitus: 2 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2018年 / 1688卷 / 1期

关键词：

D O I：

10.1007/s40278-018-41670-7

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：35 / 35

相关论文

共 50 条

[21] NivolumabType-1 diabetes mellitus, ketoacidosis and hypophysitis: case report
Reactions Weekly, 2017, 1679 (1) : 144 - 144
[22] Atezolizumab/nivolumabArthritis, diabetic ketoacidosis and type 1 diabetes mellitus: 3 case reports
Reactions Weekly, 2021, 1867 (1) : 70 - 70
[23] Atezolizumab/durvalumabAutoimmune diabetes: 2 case reports
Reactions Weekly, 2017, 1676 (1) : 51 - 51
[24] Ipilimumab/nivolumabType-1 diabetes mellitus
Reactions Weekly, 2023, 1988 (1) : 95 - 95
[25] Ipilimumab/nivolumabType 2 diabetes mellitus and diabetic ketoacidosis: case report
Reactions Weekly, 2018, 1683 (1) : 390 - 390
[26] NivolumabType-I diabetes mellitus: case report
Reactions Weekly, 2022, 1908 (1) : 443 - 443
[27] NivolumabType-1 diabetes mellitus and diabetic ketoacidosis
Reactions Weekly, 2023, 1985 (1) : 400 - 400
[28] IsotretinoinType 1 diabetes mellitus: 2 case reports
Reactions Weekly, 2019, 1751 (1) : 223 - 223
[29] TacrolimusType 1 diabetes mellitus: 2 case reports
Reactions Weekly, 2006, 1113 (1) : 17 - 17
[30] NivolumabType-1 diabetes mellitus and diabetic ketoacidosis
Reactions Weekly, 2024, 1998 (1) : 381 - 381

← 1 2 3 4 5 →